Role of glioblastoma stem cells in cancer therapeutic resistance: A perspective on antineoplastic agents from natural sources and chemical derivatives

ALV Alves, INF Gomes, AC Carloni, MN Rosa… - Stem Cell Research & …, 2021 - Springer
Glioblastoma (GBM) is the highest-grade form of glioma, as well as one of the most
aggressive types of cancer, exhibiting rapid cellular growth and highly invasive behavior …

Glioblastoma: current status, emerging targets, and recent advances

A Thakur, C Faujdar, R Sharma, S Sharma… - Journal of Medicinal …, 2022 - ACS Publications
Glioblastoma (GBM) is a highly malignant brain tumor characterized by a heterogeneous
population of genetically unstable and highly infiltrative cells that are resistant to …

Metformin and cancer, an ambiguanidous relationship

SJ Skuli, S Alomari, H Gaitsch, A Bakayoko, N Skuli… - Pharmaceuticals, 2022 - mdpi.com
The deregulation of energetic and cellular metabolism is a signature of cancer cells. Thus,
drugs targeting cancer cell metabolism may have promising therapeutic potential. Previous …

Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells

N Saini, X Yang - Acta biochimica et biophysica Sinica, 2018 - academic.oup.com
Metformin, a first line medication for type II diabetes, initially entered the spotlight as a
promising anti-cancer agent due to epidemiologic reports that found reduced cancer risk …

Targeting cancer stem cells to suppress acquired chemotherapy resistance

SJ Vidal, V Rodriguez-Bravo, M Galsky… - Oncogene, 2014 - nature.com
Acquired resistance has curtailed cancer survival since the dawn of the chemotherapy age
more than half a century ago. Although the application of stem cell (SC) concepts to cancer …

Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation

L Yan, J Zhou, Y Gao, S Ghazal, L Lu, S Bellone… - Oncogene, 2015 - nature.com
The imprinted, developmentally regulated H19 long noncoding RNA has been implicated in
the pathogenesis of diverse human cancers, but the underlying mechanisms have remained …

Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response

J Sesen, P Dahan, SJ Scotland, E Saland, VT Dang… - PloS one, 2015 - journals.plos.org
High-grade gliomas, glioblastomas (GB), are refractory to conventional treatment combining
surgery, chemotherapy, mainly temozolomide, and radiotherapy. This highlights an urgent …

Metabolic drivers of invasion in glioblastoma

JH Garcia, S Jain, MK Aghi - Frontiers in cell and developmental …, 2021 - frontiersin.org
Glioblastoma is a primary malignant brain tumor with a median survival under 2 years. The
poor prognosis glioblastoma caries is largely due to cellular invasion, which enables escape …

Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds

R Wuerth, S Thellung, A Bajetto, M Mazzanti, T Florio… - Drug discovery today, 2016 - Elsevier
Highlights•De novo anticancer drug discovery is challenging and repurposing in oncology is
a promising field.•Drug repositioning increasingly emerges as faster, cheaper and …

[HTML][HTML] Chloride channels in cancer: Focus on chloride intracellular channel 1 and 4 (CLIC1 AND CLIC4) proteins in tumor development and as novel therapeutic …

M Peretti, M Angelini, N Savalli, T Florio… - … et Biophysica Acta (BBA …, 2015 - Elsevier
In recent decades, growing scientific evidence supports the role of ion channels in the
development of different cancers. Both potassium selective pores and chloride …